These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13430482)

  • 1. [Simultaneous administration of alcohol and lipotropic drugs in chronic alcoholics; behavior of hepatic steatosis studied by serial punch biopsies].
    MENGHINI G
    Minerva Med; 1957 Feb; 48(17):661-5. PubMed ID: 13430482
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty liver with hepatic failure in alcoholics.
    POPPER H; SZANTO PB
    J Mt Sinai Hosp N Y; 1957; 24(6):1121-31. PubMed ID: 13481660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anatomopathological and biochemical correlations in chronic alcoholic steatosis].
    Bertrand JL; Mallein R; Brette R
    Lyon Med; 1972 Jan; 227(2):117-21. PubMed ID: 5017057
    [No Abstract]   [Full Text] [Related]  

  • 4. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.
    Fabris P; Floreani A; Carlotto A; Giordani MT; Baldo V; Stecca C; Marchioro L; Tramarin A; Bertin T; Negro F; de Lalla F
    J Hepatol; 2004 Oct; 41(4):644-51. PubMed ID: 15464246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.
    Mottin CC; Moretto M; Padoin AV; Kupski C; Swarowsky AM; Glock L; Duval V; da Silva JB
    Obes Surg; 2005; 15(6):788-93. PubMed ID: 15978148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatopathies in concomitance of chronic drug and alcoholic intoxications].
    Paukov VS; Ermakova OM; Kostornaia IV
    Arkh Patol; 2008; 70(5):25-9. PubMed ID: 19137779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
    Ki SH; Choi JH; Kim CW; Kim SG
    Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of hepatic microcirculation in fatty liver.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microcirculation; 2003 Dec; 10(6):447-56. PubMed ID: 14745457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
    Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
    Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial needle hepatic biopsies in a patient with fatty liver.
    SCHIFF L; GALL EA; YOUNG PC
    Gastroenterology; 1958 Jan; 34(1):135-41. PubMed ID: 13501364
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenon-133 accumulation in hepatic steatosis.
    Ahmad M; Witztum KF; Fletcher JW; Hendershott LR; Klos D; George EA; Donati RM
    J Nucl Med; 1977 Sep; 18(9):881-5. PubMed ID: 893783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etiology, morphology and biology of hepatic steatosis].
    de Werra P
    Praxis; 1967 Feb; 56(7):231-40. PubMed ID: 6072189
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alcohol induced hyperlipemia].
    Gross W; Vetter H; Juchems R
    Munch Med Wochenschr; 1969 Nov; 111(48):2493-6. PubMed ID: 5396027
    [No Abstract]   [Full Text] [Related]  

  • 20. [The fate of the liver in alcoholics. II. Use of lipotropic factors in the treatment of hepatic dysfunction].
    NADEAU G; ROULEAU Y; DELAGE J
    Laval Med; 1954 Jan; 19(1):52-8. PubMed ID: 13153180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.